ATLANTA / Feb 13, 2024 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022. Net loss for the quarter... Read More

ATLANTA / Jan 29, 2024 / Business Wire / SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, (“Trace”) to Progressive Health of Houston, LLC (“Progressive”). Southern sold certain personal and... Read More

ATLANTA / Dec 12, 2023 / Business Wire / SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink’s subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date... Read More

ATLANTA / Nov 20, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10,... Read More

ATLANTA / Nov 13, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC (“Buyer”) for the sale of the subsidiary that owns and operates Trace Regional Medical Center, which includes a hospital, skilled nursing facility and three (3) patient clinics in Chickasaw County, MS, for... Read More

ATLANTA / Sep 28, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,436,000 (or a loss of $0.20 per fully diluted share) for its fourth fiscal quarter ended June 30, 2023 compared to a loss from continuing operations of $2,317,000 (or a loss of $0.33 per fully diluted share) for the fourth fiscal quarter ended June 30, 2022. Net loss for the... Read More

ATLANTA / Aug 08, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000 th ) of a share (each a “ Series C Fractional Interest ”) of the Company’s newly-designated Series C Redeemable Preferred Shares, no par value per share (the “ Series C Preferred Shares ”), for each outstanding common share of the Company... Read More

ATLANTA / Jul 24, 2023 / Business Wire / On July 20, 2023, the board of directors (the “Board”) of SunLink Health Systems, Inc. (NYSE American: SSY) (“SSY,” the “Company,” “we,” “us” or “our”) filled a vacant seat on the Board of Directors by electing Mark J. Stockslager as a director of the Company. Mr. Stockslager, 63, has been SunLink’s Chief Financial Officer since July 1, 2007. He was interim Chief Financial Officer... Read More

ATLANTA / May 10, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $727,000 (or a loss of $0.10 per fully diluted share) for its third fiscal quarter ended March 31, 2023 compared to a loss from continuing operations of $934,000 (or a loss of $0.13 per fully diluted share) for the third fiscal quarter ended March 31, 2022. Net loss for the quarter... Read More

ATLANTA / Feb 15, 2023 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,052,000 ($0.29 per fully diluted share) for its second fiscal quarter ended December 31, 2022 compared to a loss from continuing operations of $477,000 (or a loss of $0.07 per fully diluted share) for the second fiscal quarter ended December 31, 2021. Net earnings for the... Read More